Related references
Note: Only part of the references are listed.Variations in Gnai2 and Rgs1 expression affect chemokine receptor signaling and the organization of secondary lymphoid organs
I. Y. Hwang et al.
GENES AND IMMUNITY (2010)
Targeting the dynamic HSP90 complex in cancer
Jane Trepel et al.
NATURE REVIEWS CANCER (2010)
Idiotype-pulsed antigen presenting cells following autologous transplantation for multiple myeloma may be associated with prolonged survival
Martha Q. Lacy et al.
AMERICAN JOURNAL OF HEMATOLOGY (2009)
Identification of novel antigens with induced immune response in monoclonal gammopathy of undetermined significance
Simona Blotta et al.
BLOOD (2009)
Myeloma cell line-derived, pooled heat shock proteins as a universal vaccine for immunotherapy of multiple myeloma
Jianfei Qian et al.
BLOOD (2009)
Integrated Data From 2 Randomized, Double-Blind, Placebo-Controlled, Phase 3 Trials of Active Cellular Immunotherapy With Sipuleucel-T in Advanced Prostate Cancer
Celestia S. Higano et al.
CANCER (2009)
Phase I/II study of vaccination with electrofused allogeneic dendritic Cells/Autologous tumor-derived cells in patients with stage IV renal cell carcinoma
David E. Avigan et al.
JOURNAL OF IMMUNOTHERAPY (2007)
Targeting heat shock proteins for immunotherapy in multiple myeloma: Generation of myeloma-specific CTLs using dendritic cells pulsed with tumor-derived gp96
JF Qian et al.
CLINICAL CANCER RESEARCH (2005)
NY-ESO-1 is highly expressed in poor-prognosis multiple myeloma and induces spontaneous humoral and cellular immune responses
F van Rhee et al.
BLOOD (2005)
Fusion hybrids of dendritic cells and autologous myeloid blasts as a potential cellular vaccine for acute myeloid leukaemia
M Klammer et al.
BRITISH JOURNAL OF HAEMATOLOGY (2005)
Dendritic cells loaded with stressed tumor cells elicit long-lasting protective tumor immunity in mice depleted of CD4(+)CD25(+) regulatory T cells
SJ Prasad et al.
JOURNAL OF IMMUNOLOGY (2005)
Complete response to donor lymphocyte infusion in multiple myeloma is associated with antibody responses to highly expressed antigens
R Bellucci et al.
BLOOD (2004)
Fusion cell vaccination of patients with metastatic breast and renal cancer induces immunological and clinical responses
D Avigan et al.
CLINICAL CANCER RESEARCH (2004)
Mechanisms and functional significance of tumour-induced dendritic-cell defects
D Gabrilovich
NATURE REVIEWS IMMUNOLOGY (2004)
Long-term follow-up of idiotype vaccination in human myeloma as a maintenance therapy after high-dose chemotherapy
M Coscia et al.
LEUKEMIA (2004)
Tumour cell/dendritic cell fusions as a vaccination strategy for multiple myeloma
N Raje et al.
BRITISH JOURNAL OF HAEMATOLOGY (2004)
CD4+/CD25+ regulatory cells inhibit activation of tumor-primed CD4+ T cells with IFN-γ-dependent antiangiogenic activity, as well as long-lasting tumor immunity elicited by peptide vaccination
N Casares et al.
JOURNAL OF IMMUNOLOGY (2003)
Idiotype vaccination in multiple myeloma induced a reduction of circulating clonal tumor B cells
T Rasmussen et al.
BLOOD (2003)
Hybrids of dendritic cells and tumor cells generated by electrofusion simultaneously present immunodominant epitopes from multiple human tumor-associated antigens in the context of MHC class I and class II molecules
MR Parkhurst et al.
JOURNAL OF IMMUNOLOGY (2003)
Eliciting cytotoxic T lymphocytes against acute myeloid leukemia-derived antigens: evaluation of dendritic cell-leukemia cell hybrids and other antigen-loading strategies for dendritic cell-based vaccination
J Galea-Lauri et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2002)
Tumor lysate-specific cytotoxic T lymphocytes in multiple myeloma: promising effector cells for immunotherapy
YJ Wen et al.
BLOOD (2002)
Idiotype-pulsed dendritic cell vaccination for B-cell lymphoma: clinical and immune responses in 35 patients
JM Timmerman et al.
BLOOD (2002)
Cell surface targeting of heat shock protein gp96 induces dendritic cell maturation and antitumor immunity
H Zheng et al.
JOURNAL OF IMMUNOLOGY (2001)
Idiotype-specific cytotoxic T lymphocytes in multiple myeloma: evidence for their capacity to lyse autologous primary tumor cells
YJ Wen et al.
BLOOD (2001)
Antitumor effect of immunizations with fusions of dendritic and glioma cells in a mouse brain tumor model
Y Akasaki et al.
JOURNAL OF IMMUNOTHERAPY (2001)
Fusions of human ovarian carcinoma cells with autologous or allogeneic dendritic cells induce antitumor immunity
JL Gong et al.
JOURNAL OF IMMUNOLOGY (2000)
RGS molecule expression in murine B lymphocytes and ability to down-regulate chemotaxis to lymphoid chemokines
K Reif et al.
JOURNAL OF IMMUNOLOGY (2000)
Activation of antitumor cytotoxic T lymphocytes by fusions of human dendritic cells and breast carcinoma cells
JL Gong et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2000)
Share Paper
